David A. Siegel Vera Therapeutics, Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 60,400 shares of VERA stock, worth $2.15 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
60,400Holding current value
$2.15 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
173Shares Held
52.7MCall Options Held
117KPut Options Held
290K-
Avoro Capital Advisors LLC New York, NY5.27MShares$188 Million2.74% of portfolio
-
Black Rock Inc. New York, NY3.32MShares$118 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.17MShares$113 Million11.79% of portfolio
-
Abingworth LLP London, X02.96MShares$105 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$99.5 Million7.01% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $964M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...